Back to results
US 2020/0368525 A1Published application
Methods of Treating Glioblastoma
AssigneeAbbVie Inc.
InventorsDavid MAAG, Moshe GILADI, Rosa S. SCHNAIDERMAN, Einav ZEEVI, Eilon KIRSON
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a method for treating cancer in a patient harboring an EGFR-expressing tumor and/or tumor cell, such as glioblastoma, comprising the combination of (i) applying an AC electric field to a target area, wherein the target area comprises an EGFR-expressing tumor or cancer cell); and (ii) administering an effective amount of depatuxizumab mafodotin.
Claims10
A method for treating cancer in a patient harboring an EGFR-expressing tumor, the method comprising
- (i) applying an AC electric field to a target area, wherein the target area comprises an EGFR-expressing tumor or cancer cell);
- and
- (ii) administering an effective amount of depatuxizumab mafodotin.
A method for inhibiting tumor growth, the method comprising:
- (i) applying an AC electric field to a target area, wherein the target area comprises an EGFR-expressing tumor or cancer cell) and
- (ii) administering an effective amount of depatuxizumab mafodotin.
Dependencies are inferred from the claim text.